The continually evolving Clostridium difficile species

Future Microbiology

Volumn 7, Issue 8, 2012, Pages 945-957

  Cairns, Michelle D ^a,b,c   Stabler, Richard A ^a   Shetty, Nandini ^c,d   Wren, Brendan W ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Clostridium difficile; lineages; next generation sequencing; typing; virulence

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLONAL EVOLUTION; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; DOMESTIC ANIMAL; GENOTYPING TECHNIQUE; HEALTH CARE ORGANIZATION; HOUSEKEEPING GENE; HUMAN; INCIDENCE; IRELAND; MOLECULAR EPIDEMIOLOGY; MULTICENTER STUDY (TOPIC); MULTILOCUS SEQUENCE TYPING; NETHERLANDS; NONHUMAN; PHYLOGEOGRAPHY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION MAPPING; REVIEW; RISK FACTOR;

BIOLOGICAL EVOLUTION; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CLUSTER ANALYSIS; GENETIC VARIATION; HUMANS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING;

CLOSTRIDIUM DIFFICILE; POSIBACTERIA;

EID: 84865591918     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.12.73     Document Type: Review

References (102)

1. Gould CV, Mcdonald LC. Bench-to-bedside review: CLOSTRIDIUM difficile colitis. Crit. Care 12(1), 203 (2008
2. Bartlett JG, Moon N, Chang TW, Taylor N, Onderdonk AB. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology 75(5), 778-782 (1978
3. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N. Eng. J. Med. 298(10), 531-534 (1978
4. Barbut F, Gariazzo B, Bonne L et al. Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: Results of a retrospective study, 2000-2004. Infect. Control Hosp. Epidemiol. 28(2), 131-139 (2007
5. Voth DE, Ballard JD. Clostridium difficile toxins: Mechanism of action and role in disease. Clin. Microb. Rev. 18(2), 247-263 (2005
6. Health Protection Agency, Department of Health. Clostridium difficile infection: How to deal with the problem. Department of Health, London, UK (2008
7. Ginaldi L, Loreto MF, Corsi MP, Modesti M, De Martinis M. Immunosenescence and infectious diseases. Microbes. Infect. 3(10), 851-857 (2001
8. Bartlett JG. Historical perspectives on studies of Clostridium difficile and C. difficile infection. Clin. Infect. Dis. 46(Suppl. 1), S4-S11 (2008
9. Schroeder MS. Clostridium difficile-associated diarrhea. Am. Fam. Physician 71(5), 921-928 (2005
10. Hookman P, Barkin JS. Clostridium difficile associated infection, diarrhea and colitis. World J. Gastroenterol. 15(13), 1554-1580 (2009
11. Eveillard M, Fourel V, Barc MC et al. Identification and characterization of adhesive factors of Clostridium difficile involved in adhesion to human colonic enterocyte-like Caco-2 and mucus-secreting HT29 cells in culture. Mol. Microbiol. 7(3), 371-381 (1993
12. Borriello SP, Davies HA, Kamiya S, Reed PJ, Seddon S. Virulence factors of Clostridium difficile. Rev. Infect. Dis. 12(Suppl. 2), S185-S191 (1990
13. Bianco M, Fedele G, Quattrini A et al. Immunomodulatory activities of surface-layer proteins obtained from epidemic and hypervirulent Clostridium difficile strains. J. Med. Microbiol. 60(Pt 8), 1162-1167 (2011
14. Dawson LF, Donahue EH, Cartman ST et al. The analysis of para-cresol production and tolerance in Clostridium difficile 027 and 012 strains. BMC Microbiology 11, 86 (2011
15. Dupuy B, Govind R, Antunes A, Matamouros S. Clostridium difficile toxin synthesis is negatively regulated by TcdC. J. Med. Microbiol. 57(Pt 6), 685-689 (2008
16. Murray R, Boyd D, Levett PN, Mulvey MR, Alfa MJ. Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of toxin B or toxin A. BMC Infect. Dis. 9, 103 (2009
17. Popoff MR, Rubin EJ, Gill DM, Boquet P. Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect. Immun. 56(9), 2299-2306 (1988
18. Goncalves C, Decre D, Barbut F, Burghoffer B, Petit JC. Prevalence and characterization of a binary toxin (actin-specific ADP-ribosyltransferase) from Clostridium difficile. J. Clin. Microbiol. 42(5), 1933-1939 (2004
19. Schwan C, Stecher B, Tzivelekidis T et al. Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria. PLoS Pathog. 5(10), e1000626 (2009
20. Owens RC. Clostridium difficile-associated disease: Changing epidemiology and implications for management. Drugs 67(4), 487-502 (2007
21. Louie TJ, Miller MA, Mullane KM et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N. Eng. J. Med. 364(5), 422-431 (2011
22. Guo B, Harstall C, Louie T, Veldhuyzen Van Zanten S, Dieleman LA. Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease. Aliment. Pharmacol. Ther. 35(8), 865-875 (2012
23. Lo Vecchio A, Zacur GM. Clostridium difficile infection: An update on epidemiology, risk factors, and therapeutic options. Curr. Opin. Gastroenterol. 28(1), 1-9 (2012
24. Killgore G, Thompson A, Johnson S et al. Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: Restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. J. Clin. Microbiol. 46(2), 431-437 (2008
25. Maiden MC. Multilocus sequence typing of bacteria. Ann. Rev. Microbiol. 60, 561-588 (2006
26. Lemee L, Dhalluin A, Pestel-Caron M, Lemeland JF, Pons JL. Multilocus sequence typing analysis of human and animal Clostridium difficile isolates of various toxigenic types. J. Clin. Microbiol. 42(6), 2609-2617 (2004
27. Lemee L, Bourgeois I, Ruffin E, Collignon A, Lemeland JF, Pons JL. Multilocus sequence analysis and comparative evolution of virulence-associated genes and housekeeping genes of Clostridium difficile. Microbiology 151(Pt 10), 3171-3180 (2005
28. Griffiths D, Fawley W, Kachrimanidou M et al. Multilocus sequence typing of Clostridium difficile. J. Clin. Microbiol. 48(3), 770-778 (2010
29. Dingle KE, Griffiths D, Didelot X et al. Clinical Clostridium difficile: Clonality and pathogenicity locus diversity. PLoS One 6(5), e19993 (2011
30. Stabler RA, Dawson LF, Valiente E et al. Macro and micro diversity of Clostridium difficile isolates from diverse sources and geographical locations. PloS one 7(3), e31559 (2012
31. Pepin J, Valiquette L, Alary ME et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: A changing pattern of disease severity. CMAJ 171(5), 466-472 (2004
32. Healthcare Commission. Investigation into outbreaks of Clostridium difficile at Maidstone and Tunbridge Wells. Commission for Healthcare Audit and Inspection, London, UK (2007
33. Loo VG, Poirier L, Miller MA et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N. Eng. J. Med. 353(23), 2442-2449 (2005
34. Hubert B, Loo VG, Bourgault AM et al. A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Quebec. Clin. Infect. Dis. 44(2), 238-244 (2007
35. Van Steenbergen J, Debast S, Van Kregten E, Van Den Berg R, Notermans D, Kuijper E. Isolation of Clostridium difficile ribotype 027, toxinotype III in The Netherlands after increase in C. difficile-associated diarrhoea. Euro Surveill. 10(7), E050714.1 (2005
36. Kuijper EJ, Barbut F, Brazier JS et al. Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill. 13(31), pii: 18942 (2008
37. Indra A, Huhulescu S, Fiedler A, Kernbichler S, Blaschitz M, Allerberger F. Outbreak of Clostridium difficile 027 infection in Vienna, Austria 2008-2009. Euro Surveill. 14(17), pii: 19186 (2009
38. Bacci S, St-Martin G, Olesen B et al. Outbreak of Clostridium difficile 027 in North Zealand, Denmark, 2008-2009. Euro Surveill. 14(16), pii: 19183 (2009
39. Riley TV, Thean S, Hool G, Golledge CL. First Australian isolation of epidemic Clostridium difficile PCR ribotype 027. Med. J. Aust. 190(12), 706-708 (2009
40. Tae CH, Jung SA, Song HJ et al. The first case of antibiotic-associated colitis by Clostridium difficile PCR ribotype 027 in Korea. J. Korean Med. Sci. 24(3), 520-524 (2009
41. Kato H, Ito Y, Van Den Berg RJ, Kuijper EJ, Arakawa Y. First isolation of Clostridium difficile 027 in Japan. Euro Surveill. 12(1), E070111.3 (2007
42. Cheng VC, Yam WC, Chan JF, To KK, Ho PL, Yuen KY. Clostridium difficile ribotype 027 arrives in Hong Kong. Int. J. Antimicrob. Agents 34(5), 492-493 (2009
43. Quesada-Gomez C, Rodriguez C, Gamboa- Coronado Mdel M et al. Emergence of Clostridium difficile NAP1 in Latin America. J. Clin. Microbiol. 48(2), 669-670 (2010
44. Borriello SP. Pathogenesis of Clostridium difficile infection. J. Antimicrob. Chemother. 41(Suppl. C), 13-19 (1998
45. Mccusker ME, Harris AD, Perencevich E, Roghmann MC. Fluoroquinolone use and Clostridium difficile-associated diarrhea. Emerg. Infect. Dis. 9(6), 730-733 (2003
46. Phillips ST, Nagaro K, Sambol SP, Johnson S, Gerding DN. Susceptibility of hamsters to infection by historic and epidemic BI Clostridium difficile strains during daily administration of three fluoroquinolones. Anaerobe 17(4), 166-169 (2011
47. Deshpande A, Pant C, Jain A, Fraser TG, Rolston DD. Do fluoroquinolones predispose patients to Clostridium difficile associated disease? A review of the evidence. Curr. Med. Res. Opin. 24(2), 329-333 (2008
48. Mcdonald LC, Killgore GE, Thompson A et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N. Eng. J. Med. 353(23), 2433-2441 (2005
49. Warny M, Pepin J, Fang A et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366(9491), 1079-1084 (2005
50. Maccannell DR, Louie TJ, Gregson DB et al. Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and western Canada. J. Clin. Microbiol. 44(6), 2147-2152 (2006
51. Curry SR, Marsh JW, Muto CA, O'leary MM, Pasculle AW, Harrison LH. tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile. J. Clin. Microbiol. 45(1), 215-221 (2007
52. Freeman J, Baines SD, Saxton K, Wilcox MH. Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut model. J. Antimicrob. Chemother. 60(1), 83-91 (2007
53. Fawley WN, Underwood S, Freeman J et al. Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strains. Infect. Control Hosp. Epidemiol. 28(8), 920-925 (2007
54. Burns DA, Heap JT, Minton NP. The diverse sporulation characteristics of Clostridium difficile clinical isolates are not associated with type. Anaerobe 16(6), 618-622 (2010
55. Burns DA, Heeg D, Cartman ST, Minton NP. Reconsidering the sporulation characteristics of hypervirulent Clostridium difficile BI/NAP1/027. PLoS One 6(9), e24894 (2011
56. Stabler RA, He M, Dawson L et al. Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol. 10(9), R102 (2009
57. Alfa MJ, Kabani A, Lyerly D et al. Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. J. Clin. Microbiol. 38(7), 2706-2714 (2000
58. Kuijper EJ, De Weerdt J, Kato H et al. Nosocomial outbreak of Clostridium difficile-associated diarrhoea due to a clindamycin-resistant enterotoxin A-negative strain. Eur. J. Clin. Microbiol. Infect. Dis. 20(8), 528-534 (2001
59. Komatsu M, Kato H, Aihara M et al. High frequency of antibiotic- associated diarrhea due to toxin A-negative, toxin B-positive Clostridium difficile in a hospital in Japan and risk factors for infection. Eur. J. Clin. Microbiol. Infect. Dis. 22(9), 525-529 (2003
60. Drudy D, Harnedy N, Fanning S, Hannan M, Kyne L. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile. Infect. Control Hosp. Epidemiol. 28(8), 932-940 (2007
61. Johnson S, Sambol SP, Brazier JS et al. International typing study of toxin A-negative, toxin B-positive Clostridium difficile variants. J. Clin. Microbiol. 41(4), 1543-1547 (2003
62. Pituch H, Brazier JS, Obuch-Woszczatynski P, Wultanska D, Meisel-Mikolajczyk F, Luczak M. Prevalence and association of PCR ribotypes of Clostridium difficile isolated from symptomatic patients from Warsaw with macrolide-lincosamide-streptogramin B (MLSB) type resistance. J. Med. Microbiol. 55(Pt 2), 207-213 (2006
63. Huang H, Weintraub A, Fang H, Wu S, Zhang Y, Nord CE. Antimicrobial susceptibility and heteroresistance in Chinese Clostridium difficile strains. Anaerobe 16(6), 633-635 (2010
64. Kim H, Jeong SH, Roh KH et al. Investigation of toxin gene diversity, molecular epidemiology, and antimicrobial resistance of Clostridium difficile isolated from 12 hospitals in South Korea. Korean J. Lab. Med. 30(5), 491-497 (2010
65. Kim SJ, Kim H, Seo Y et al. Molecular characterization of toxin A-negative, toxin B-positive variant strains of Clostridium difficile isolated in Korea. Diagn. Microbiol. Infect. Dis. 67(2), 198-201 (2010
66. Goorhuis A, Legaria MC, Van Den Berg RJ et al. Application of multiple-locus variable-number tandem-repeat analysis to determine clonal spread of toxin A-negative Clostridium difficile in a general hospital in Buenos Aires, Argentina. Clin. Microbiol. Infect. 15(12), 1080-1086 (2009
67. Shin BM, Kuak EY, Yoo SJ, Shin WC, Yoo HM. Emerging toxin A-B+ variant strain of Clostridium difficile responsible for pseudomembranous colitis at a tertiary care hospital in Korea. Diagn. Microbiol. Infect. Dis. 60(4), 333-337 (2008
68. Elliott B, Reed R, Chang BJ, Riley TV. Bacteremia with a large clostridial toxin-negative, binary toxin-positive strain of Clostridium difficile. Anaerobe 15(6), 249-251 (2009
69. Samra Z, Talmor S, Bahar J. High prevalence of toxin A-negative toxin B-positive Clostridium difficile in hospitalized patients with gastrointestinal disease. Diagn. Microbiol. Infect. Dis. 43(3), 189-192 (2002
70. Rupnik M, Kato N, Grabnar M, Kato H. New types of toxin A-negative, toxin B-positive strains among Clostridium difficile isolates from Asia. J. Clin. Microbiol. 41(3), 1118-1125 (2003
71. Shin BM, Kuak EY, Yoo HM et al. Multicentre study of the prevalence of toxigenic Clostridium difficile in Korea: Results of a retrospective study 2000-2005. J. Med. Microbiol. 57(Pt 6), 697-701 (2008
72. Kim H, Riley TV, Kim M et al. Increasing prevalence of toxin A-negative, toxin B-positive isolates of Clostridium difficile in Korea: Impact on laboratory diagnosis. J. Clin. Microbiol. 46(3), 1116-1117 (2008
73. O'Neill G, Adams JE, Bowman RA, Riley TV. A molecular characterization of Clostridium difficile isolates from humans, animals and their environments. Epidemiol. Infect. 111(2), 257-264 (1993
74. Songer JG. The emergence of Clostridium difficile as a pathogen of food animals. Anim. Health Res. Rev. 5(2), 321-326 (2004
75. Arroyo LG, Kruth SA, Willey BM, Staempfli HR, Low DE, Weese JS. PCR ribotyping of Clostridium difficile isolates originating from human and animal sources. J. Med. Microbiol. 54(Pt 2), 163-166 (2005
76. Songer JG, Anderson MA. Clostridium difficile: An important pathogen of food animals. Anaerobe 12(1), 1-4 (2006
77. Rodriguez-Palacios A, Reid-Smith RJ, Staempfli HR et al. Possible seasonality of Clostridium difficile in retail meat, Canada. Emerg. Infect. Dis. 15(5), 802-805 (2009
78. Keel K, Brazier JS, Post KW, Weese S, Songer JG. Prevalence of PCR ribotypes among Clostridium difficile isolates from pigs, calves, and other species. J. Clin. Microbiol. 45(6), 1963-1964 (2007
79. Pirs T, Ocepek M, Rupnik M. Isolation of Clostridium difficile from food animals in Slovenia. J. Med. Microbiol. 57(Pt 6), 790-792 (2008
80. Jhung MA, Thompson AD, Killgore GE et al. Toxinotype V Clostridium difficile in humans and food animals. Emerg. Infect. Dis. 14(7), 1039-1045 (2008
81. Goorhuis A, Bakker D, Corver J et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin. Infect. Dis. 47(9), 1162-1170 (2008
82. Rupnik M, Widmer A, Zimmermann O, Eckert C, Barbut F. Clostridium difficile toxinotype V, ribotype 078, in animals and humans. J. Clin. Microbiol. 46(6), 2146 (2008
83. Broda DM, Delacy KM, Bell RG, Penney N. Association of psychrotrophic Clostridium spp. with deep tissue spoilage of chilled vacuum-packed lamb. Int. J. Food Microbiol. 29(2-3), 371-378 (1996
84. Songer JG, Trinh HT, Killgore GE, Thompson AD, Mcdonald LC, Limbago BM. Clostridium difficile in retail meat products, USA, 2007. Emerg. Infect. Dis. 15(5), 819-821 (2009
85. Simango C, Mwakurudza S. Clostridium difficile in broiler chickens sold at market places in Zimbabwe and their antimicrobial susceptibility. Int. J. Food Microbiol. 124(3), 268-270 (2008
86. Metcalf D, Avery BP, Janecko N, Matic N, Reid-Smith R, Weese JS. Clostridium difficile in seafood and fish. Anaerobe 17(2), 85-86 (2011
87. Khanna S, Pardi DS, Aronson SL et al. The epidemiology of community-acquired Clostridium difficile infection: A population-based study. Am. J. Gastroenterol. 107(1), 89-95 (2012
88. Debast SB, Van Leengoed LA, Goorhuis A, Harmanus C, Kuijper EJ, Bergwerff AA. Clostridium difficile PCR ribotype 078 toxinotype V found in diarrhoeal pigs identical to isolates from affected humans. Environ. Microbiol. 11(2), 505-511 (2009
89. Rupnik M, Brazier JS, Duerden BI, Grabnar M, Stubbs SL. Comparison of toxinotyping and PCR ribotyping of Clostridium difficile strains and description of novel toxinotypes. Microbiology 147(Pt 2), 439-447 (2001
90. Knetsch CW, Hensgens MP, Harmanus C et al. Genetic markers for Clostridium difficile lineages linked to hypervirulence. Microbiology 157(Pt 11), 3113-3123 (2011
91. Stabler RA, Gerding DN, Songer JG et al. Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains. J. Bacteriol. 188(20), 7297-7305 (2006
92. Bauer MP, Notermans DW, Van Benthem BH et al. Clostridium difficile infection in Europe: A hospital-based survey. Lancet 377(9759), 63-73 (2011
93. Barbut F, Mastrantonio P, Delmee M et al. Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin. Microbiol. Infect. 13(11), 1048-1057 (2007
94. Wren MW, Kinson R, Sivapalan M, Shemko M, Shetty NR. Detection of Clostridium difficile infection: A suggested laboratory diagnostic algorithm. Br. J. Biomed. Sci. 66(4), 175-179 (2009
95. Valiente E, Dawson LF, Cairns MD, Stabler RA, Wren BW. Emergence of new PCR ribotypes from the hypervirulent Clostridium difficile 027 lineage. J. Med. Microbiol. 61(Pt 1), 49-56 (2012
96. Elliott B, Squire MM, Thean S et al. New types of toxin A-negative, toxin B-positive strains among clinical isolates of Clostridium difficile in Australia. J. Med. Microbiol. 60(Pt 8), 1108-1111 (2011
97. Parkhill J, Wren BW. Bacterial epidemiology and biology - lessons from genome sequencing. Genome Biol. 12(10), 230 (2011
98. Chin CS, Sorenson J, Harris JB et al. The origin of the Haitian cholera outbreak strain. N. Eng. J. Med. 364(1), 33-42 (2011
99. Harris SR, Feil EJ, Holden MT et al. Evolution of MRSA during hospital transmission and intercontinental spread. Science 327(5964), 469-474 (2010
100. He M, Sebaihia M, Lawley TD et al. Evolutionary dynamics of Clostridium difficile over short and long time scales. Proc. Natl Acad. Sci. USA 107(16), 7527-7532 (2010
101. Goorhuis A, Van Der Kooi T, Vaessen N et al. Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin. Infect. Dis. 45(6), 695-703 (2007
102. Walker AS, Eyre DW, Wyllie DH et al. Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing. PLoS Med. 9(2), e1001172 (2012